Veracyte: Q2 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Tuesday reported a loss of $9.5 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 13 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.
The molecular diagnostic company posted revenue of $72.9 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $67.4 million.
Veracyte expects full-year revenue in the range of $272 million to $280 million.